RNA Q1 2020 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

RNAAvidity Biosciences, Inc.

$2B

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M

Gross Profit

$1M100.0% margin

Operating Income

-$6M-452.9% margin

Net Income

-$6M-448.1% margin

EPS (Diluted)

$-0.20

QoQ Revenue Growth

-6.0%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$449,000

Balance Sheet

Total Assets

$93M

Total Liabilities

$27M

Stockholders' Equity

$66M

Cash & Equivalents

$89M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$0	—
Gross Profit	$1M	-$1M	+207.6%
Operating Income	-$6M	-$2M	-182.9%
Net Income	-$6M	-$3M	-138.7%